Vincristine

Search results for Vincristine

Found 1955 articles. Showing from 1 to 10.

The Journal of reproductive medicine (2012-06-15)
High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.

The Journal of reproductive medicine (2011-06-20)
Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.

International journal of radiation oncology, biology, physics (2012-01-16)
Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.

Cancer (2012-08-21)
Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.

Journal of clinical oncology (2010-10-19)
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

Cancer (2012-06-19)
Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.

Cancer (2012-08-17)
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.

Journal of clinical oncology (2012-10-01)
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Journal of clinical oncology (2010-10-19)
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.

Clinical cancer research (2012-04-17)
Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma.

« Previous
1
2
3
4
5
6
7
8
9
10
11
Next »

Filters

Journals

Categories

Subjects

Year of publication

Español | English

© Galenicom 1999-2013